Estrogen and signaling in the cells of immune system

Advances in Neuroimmune Biology

Volumn 3, Issue 1, 2012, Pages 73-93

  Khan, Deena ^a   Cowan, Catharine ^a   Ahmed, S Ansar ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

autoimmune; cytokine; Estrogen; immune; receptor

Indexed keywords

ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MICRORNA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; DISEASE COURSE; ESTROGEN SYNTHESIS; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOBIOLOGY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; MICROARRAY ANALYSIS; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84861997108     PISSN: 1878948X     EISSN: 18789498     Source Type: Journal    
DOI: 10.3233/NIB-2012-012039     Document Type: Article

References (235)

1. Gustafsson JA. What pharmacologists can learn from recent advances in estrogen signalling. Trends Pharmacol Sci. 2003; 24(9): 479-485. Epub 2003/09/12.
2. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. The New England Journal of Medicine. 1997; 337(2): 91-95. Epub 1997/07/10.
3. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. The New England Journal of Medicine. 1994; 331(16): 1056-1061. Epub 1994/10/20.
4. Herrmann BL, Saller B, Janssen OE, Gocke P, Bockisch A, Sperling H, et al. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab. 2002; 87(12): 5476-5484. Epub 2002/12/06.
5. Gruber DM, Huber JC. Conjugated estrogens-the natural SERMs. Gynecological endocrinology: the Official Journal of the International Society of Gynecological Endocrinology. 1999; 13(Suppl 6): 9-12. Epub 2000/06/22.
6. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997; 138(3): 863-870. (Pubitemid 27089735)
7. Cutolo M, Villaggio B, Seriolo B, Montagna P, Capellino S, Straub RH, et al. Synovial fluid estrogens in rheumatoid arthritis. Autoimmunity Reviews. 2004; 3(3): 193-198. Epub 2004/04/28.
8. Miller L, Hughes JP. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: Arandomized trial. Obstet Gynecol. 2003; 101(4): 653-661. Epub 2003/04/10.
9. Katzenellenbogen BS, Katzenellenbogen JA. Biomedicine. Defining the "S" in SERMs. Science. 2002; 295(5564): 2380-2381. Epub 2002/03/30.
10. Bolger R, Wiese TE, Ervin K, Nestich S, Checovich W. Rapid screening of environmental chemicals for estrogen receptor binding capacity. Environ Health Perspect. 1998; 106(9): 551-557. Epub 1998/08/29.
11. Waring RH, Harris RM. Endocrine disrupters: a human risk? Mol Cell Endocrinol. 2005; 244(1-2): 2-9. Epub 2005/11/08.
12. Lathers CM. Endocrine disruptors: A new scientific role for clinical pharmacologists? Impact on human health, wildlife, and the environment. J Clin Pharmacol. 2002; 42(1): 7-23. Epub 2002/01/26.
13. Ahmed SA. The immune system as a potential target for environmental estrogens (endocrine disrupters): a new emerging field. Toxicology. 2000; 150(1-3): 191-206.
14. Milla S, Depiereux S, Kestemont P. The effects of estrogenic and androgenic endocrine disruptors on the immune system of fish: a review. Ecotoxicology. 2011; 20(2): 305-319. Epub 2011/01/07.
15. Jordan VC, Mittal S, Gosden B, Koch R, Lieberman ME. Structure-activity relationships of estrogens. Environ Health Perspect. 1985; 61: 97-110. Epub 1985/09/01.
16. Chalubinski M, Kowalski ML. Endocrine disrupters-potential modulators of the immune system and allergic response. Allergy. 2006; 61(11): 1326-1335. Epub 2006/09/28.
17. Marin DE, Taranu I, Burlacu R, Manda G, Motiu M, Neagoe I, et al. Effects of zearalenone and its derivatives on porcine immune response. Toxicol In Vitro. 2011. Epub 2011/07/19.
18. Cunningham JG, Klein BG. Texbook of Veterinary Physiology. 4th ed: Saunders Elsevier; 2007.
19. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol. 2003; 86(3-5): 225-230. (Pubitemid 37412561)
20. Labrie F, Belanger A, Luu-The V, Labrie C, Simard J, Cusan L, et al. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging Steroids. 1998; 63(5-6): 322-328. (Pubitemid 28265670)
21. Bebo BF Jr, Fyfe-Johnson A, Adlard K, Beam AG, Vandenbark AA, Offner H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. Journal of immunology. 2001; 166(3): 2080-2089. (Pubitemid 32114698)
22. Couse JF, Korach KS. Estrogen receptor null mice: What have we learned and where will they lead us? Endocr Rev. 1999; 20(3): 358-417. Epub 1999/06/16.
23. Walmer DK, Wrona MA, Hughes CL, Nelson KG. Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone. Endocrinology. 1992; 131(3): 1458-1466. Epub 1992/09/01.
24. Askanase AD, Buyon JP. Reproductive health in SLE. Best practice & research Clinical rheumatology. 2002; 16(2): 265-280. Epub 2002/06/04.
25. Levitz M, Young BK. Estrogens in pregnancy. Vitamins and Hormones. 1977; 35: 109-147. Epub 1977/01/01.
26. Dogru MT, Basar MM, Yuvanc E, Simsek V, Sahin O. The relationship between serum sex steroid levels and heart rate variability parameters in males and the effect of age. Turk Kardiyoloji Dernegi arsivi: Turk Kardiyoloji Derneginin yayin organidir. 2010; 38(7): 459-465. Epub 2011/01/06.
27. Rosenbaum W, Christy NP, Kelly WG. Electrophoretic evidence for the presence of an estrogen-binding beta-globulin in human plasma. J Clin Endocrinol Metab. 1966; 26(12): 1399-1403. Epub 1966/12/01.
28. Rosner W, Hryb DJ, Kahn SM, Nakhla AM, Romas NA. Interactions of sex hormone-binding globulin with target cells. Mol Cell Endocrinol. 2010; 316(1): 79-85. Epub 2009/08/25.
29. Rosner M, Fuchs C, Siegel N, Valli A, Hengstschlager M. Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle. Hum Mol Genet. 2009; 18(17): 3298-3310. Epub 2009/06/10.
30. Jensen EV. On the mechanism of estrogen action. Perspect Biol Med. 1962; 6: 47-59. Epub 1962/01/01.
31. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proceedings of the National Academy of Sciences of the United States of America. 1996; 93(12): 5925-5930. Epub 1996/06/11.
32. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proceedings of the National Academy of Sciences of the United States of America. 1998; 95(26): 15677-15682. Epub 1998/ 12/23.
33. Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G, et al. Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J. 2000; 19(17): 4688-4700. Epub 2000/09/06.
34. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF. Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem Biophys Res Commun. 2005; 336(4): 1023-1027. Epub 2005/09/17.
35. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, et al. Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A. Nature. 1986; 320(6058): 134-139. Epub 1986/03/13.
36. Leygue E, Dotzlaw H, Lu B, Glor C, Watson PH, Murphy LC. Estrogen receptor beta: Mine is longer than yours? J Clin Endocrinol Metab. 1998; 83(10): 3754-3755. Epub 1998/10/13.
37. Inoue S, Ogawa S, Horie K, Hoshino S, Goto W, Hosoi T, et al. An estrogen receptor beta isoform that lacks exon 5 has dominant negative activity on both ERalpha and ERbeta. Biochem Biophys Res Commun. 2000; 279(3): 814-819. Epub 2001/02/13.
38. Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, et al. Cloning and characterization of human estrogen receptor beta isoforms. Biochem Biophys Res Commun. 1998; 247(1): 75-78. Epub 1998/06/24.
39. Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y, et al. Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. Nucleic Acids Res. 1998; 26(15): 3505-3512. Epub 1998/07/22.
40. Poola I, Abraham J, Baldwin K, Saunders A, Bhatnagar R. Estrogen receptors beta4 and beta5 are full length functionally distinct ERbeta isoforms: cloning from human ovary and functional characterization. Endocrine. 2005; 27(3): 227-238. Epub 2005/10/19.
41. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, et al. Estrogen receptors: How do they signal and what are their targets. Physiol Rev. 2007; 87(3): 905-931. Epub 2007/07/07.
42. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 1997; 389(6652): 753-758. Epub 1997/10/24 21:29.
43. Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS letters. 1996; 392(1): 49-53. (Pubitemid 26268330)
44. Shughrue PJ, Komm B, Merchenthaler I. The distribution of estrogen receptor-beta mRNA in the rat hypothalamus. Steroids. 1996; 61(12): 678-681. Epub 1996/12/01.
45. Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology. 1997; 138(11): 4613-4621. Epub 1997/11/05.
46. Hiroi H, Inoue S, Watanabe T, Goto W, Orimo A, Momoeda M, et al. Differential immunolocalization of estrogen receptor alpha and beta in rat ovary and uterus. JMol Endocrinol. 1999; 22(1): 37-44. Epub 1999/01/30.
47. Sar M, Welsch F. Differential expression of estrogen receptor-beta and estrogen receptor-alpha in the rat ovary. Endocrinology. 1999; 140(2): 963-971. Epub 1999/02/02.
48. Nishihara E, Nagayama Y, Inoue S, Hiroi H, Muramatsu M, Yamashita S, et al. Ontogenetic changes in the expression of estrogen receptor alpha and beta in rat pituitary gland detected by immunohistochemistry. Endocrinology. 2000; 141(2): 615-20. Epub 2000/01/29.
49. Brandenberger AW, Tee MK, Lee JY, Chao V, Jaffe RB. Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus. J Clin Endocrinol Metab. 1997; 82(10): 3509-3512. Epub 1997/11/05.
50. Carreras E, Turner S, Paharkova-Vatchkova V, Mao A, Dascher C, Kovats S. Estradiol acts directly on bone marrow myeloid progenitors to differentially regulate GM-CSF or Flt3 ligand-mediated dendritic cell differentiation. Journal of Immunology. 2008; 180(2): 727-738. Epub 2008/ 01/08.
51. Seiki K, Sakabe K. Sex hormones and the thymus in relation to thymocyte proliferation and maturation. Arch Histol Cytol. 1997; 60(1): 29-38. (Pubitemid 27251356)
52. Smithson G, Medina K, Ponting I, Kincade PW. Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. Journal of Immunology. 1995; 155(7): 3409-3417.
53. Kawashima I, Seiki K, Sakabe K, Ihara S, Akatsuka A, Katsumata Y. Localization of estrogen receptors and estrogen receptor-mRNA in female mouse thymus. Thymus. 1992; 20(2): 115-121. Epub 1992/09/01.
54. Mor G, Munoz A, Redlinger R Jr., Silva I, Song J, Lim C, et al. The role of the Fas/Fas ligand system in estrogen-induced thymic alteration. Am J Reprod Immunol. 2001; 46(4): 298-307. (Pubitemid 32926911)
55. Lambert KC, Curran EM, Judy BM, Lubahn DB, Estes DM. Estrogen receptor-alpha deficiency promotes increased TNF-alpha secretion and bacterial killing by murine macrophages in response to microbial stimuli in vitro. Journal of Leukocyte Biology. 2004; 75(6): 1166-1172. Epub 2004/03/17.
56. Vidal O, Kindblom LG, Ohlsson C. Expression and localization of estrogen receptor-beta in murine and human bone. J Bone Miner Res. 1999; 14(6): 923-929. Epub 1999/06/03.
57. Smithson G, Couse JF, Lubahn DB, Korach KS, Kincade PW. The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. Journal of Immunology. 1998; 161(1): 27-34. (Pubitemid 28285502)
58. Erlandsson MC, Ohlsson C, Gustafsson JA, Carlsten H. Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus. Immunology. 2001; 103(1): 17-25. (Pubitemid 32453095)
59. Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. The Journal of Clinical Investigation. 2002; 109(12): 1625-1633. (Pubitemid 34663525)
60. Phiel KL, Henderson RA, Adelman SJ, Elloso MM. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett. 2005; 97(1): 107-113. Epub 2005/01/01.
61. Nancy P, Berrih-Aknin S. Differential estrogen receptor expression in autoimmune myasthenia gravis. Endocrinology. 2005; 146(5): 2345-2353. Epub 2005/01/22.
62. Pierdominici M, Maselli A, Colasanti T, Giammarioli AM, Delunardo F, Vacirca D, et al. Estrogen receptor profiles in human peripheral blood lymphocytes. Immunology Letters. 2010; 132(1-2): 79-85. Epub 2010/06/15.
63. Panchanathan R, Shen H, Zhang X, Ho SM, Choubey D. Mutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity. PloS One. 2010; 5(5): e10868. Epub 2010/06/09.
64. Staples JE, Gasiewicz TA, Fiore NC, Lubahn DB, Korach KS, Silverstone AE. Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations. Journal of Immunology. 1999; 163(8): 4168-74. (Pubitemid 29474479)
65. Shim GJ, Kis LL, Warner M, Gustafsson JA. Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101(6): 1720-1724. Epub 2004/01/28.
66. Maret A, Coudert JD, Garidou L, Foucras G, Gourdy P, Krust A, et al. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. European Journal of Immunology. 2003; 33(2): 512-521. (Pubitemid 36267617)
67. Shim GJ, Wang L, Andersson S, Nagy N, Kis LL, Zhang Q, et al. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100(11): 6694-6699. (Pubitemid 36675339)
68. Erlandsson MC, Jonsson CA, Islander U, Ohlsson C, Carlsten H. Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice. Immunology. 2003; 108(3): 346-351. (Pubitemid 36332393)
69. Matthews J, Wihlen B, Tujague M, Wan J, Strom A, Gustafsson JA. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Mol Endocrinol. 2006; 20(3): 534-543. Epub 2005/11/19.
70. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/ antagonists. Mol Pharmacol. 1998; 54(1): 105-112. Epub 1998/07/11.
71. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, et al. Mechanisms of estrogen action. Physiol Rev. 2001; 81(4): 1535-1565. (Pubitemid 32951806)
72. Levin ER. Plasma membrane estrogen receptors. Trends Endocrinol Metab. 2009; 20(10): 477-482. Epub 2009/09/29.
73. Nilsson S, Gustafsson JA. Estrogen receptors: therapies targeted to receptor subtypes. Clin Pharmacol Ther. 2011; 89(1): 44-55. Epub 2010/12/03.
74. Bramlett KS, Wu Y, Burris TP. Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes. Mol Endocrinol. 2001; 15(6): 909-922. Epub 2001/05/29.
75. McInerney EM, Tsai MJ, O'Malley BW, Katzenellenbogen BS. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proceedings of the National Academy of Sciences of the United States of America. 1996; 93(19): 10069-10073. (Pubitemid 26314575)
76. O'Lone R, Frith MC, Karlsson EK, Hansen U. Genomic targets of nuclear estrogen receptors. Mol Endocrinol. 2004; 18(8): 1859-1875. Epub 2004/03/20.
77. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, et al. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol. 2000; 74(5): 311-317. (Pubitemid 32126243)
78. Biswas DK, Singh S, Shi Q, Pardee AB, Iglehart JD. Cross-roads of estrogen receptor and NF-kappaB signaling. Sci STKE. 2005; 2005(288): pe27. Epub 2005/06/16.
79. Fox EM, Andrade J, Shupnik MA. Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways. Steroids. 2009; 74(7): 622-627. Epub 2008/11/11.
80. Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, et al. Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem. 2000; 275(8): 5379-5387. Epub 2000/02/22.
81. Bjornstrom L, Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol. 2005; 19(4): 833-842. (Pubitemid 40397050)
82. Ghisletti S, Meda C, Maggi A, Vegeto E. 17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization. Mol Cell Biol. 2005; 25(8): 2957-2968. Epub 2005/03/31.
83. Dai R, Phillips RA, Ahmed SA. Despite inhibition of nuclear localization of NF-kappa B p65, c-Rel, and RelB, 17-beta estradiol up-regulates NF-kappa B signaling in mouse splenocytes: the potential role of Bcl-3. Journal of Immunology. 2007; 179(3): 1776-1783. Epub 2007/07/21.
84. Dai R, Phillips RA, Karpuzoglu E, Khan D, Ahmed SA. Estrogen regulates transcription factors STAT-1 and NF-kappaB to promote inducible nitric oxide synthase and inflammatory responses. Journal of Immunology. 2009; 183(11): 6998-7005. Epub 2009/11/06.
85. Straub RH. The complex role of estrogens in inflammation. Endocrine reviews. 2007; 28(5): 521-574. Epub 2007/07/21.
86. Hammes SR, Levin ER. Extranuclear steroid receptors: nature and actions. Endocrine Reviews. 2007; 28(7): 726-741. Epub 2007/10/06.
87. Kang L, Zhang X, Xie Y, Tu Y, Wang D, Liu Z, et al. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol. 2010; 24(4): 709-21. Epub 2010/03/04.
88. Isensee J, Meoli L, Zazzu V, Nabzdyk C, Witt H, Soewarto D, et al. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology. 2009; 150(4): 1722-1730. Epub 2008/12/20.
89. Kassi E, Moutsatsou P. Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus. J Biomed Biotechnol. 2010; 2010: 317452. Epub 2010/07/10.
90. Bruce-Keller AJ, Barger SW, Moss NI, Pham JT, Keller JN, Nath A. Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17 beta-estradiol. J Neurochem. 2001; 78(6): 1315-1324. Epub 2001/10/02.
91. Bruce-Keller AJ, Keeling JL, Keller JN, Huang FF, Camondola S, Mattson MP. Antiinflammatory effects of estrogen on microglial activation. Endocrinology. 2000; 141(10): 3646-3656. Epub 2000/10/03.
92. Friedrich EB, Clever YP, Wassmann S, Hess C, Nickenig G. 17Beta-estradiol inhibits monocyte adhesion via down-regulation of Rac1 GTPase. J Mol Cell Cardiol. 2006; 40(1): 87-95. Epub 2005/12/08.
93. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 1995; 270(5241): 1491-1494. Epub 1995/12/01.
94. Gee JM, Robertson JF, Gutteridge E, Ellis IO, Pinder SE, Rubini M, et al. Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. Endocr Relat Cancer. 2005; 12 (Suppl 1): S99-S111. Epub 2005/08/23.
95. Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med. 2006; 27(4): 299-402. Epub 2006/08/18.
96. Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update. 2005; 11(4): 411-23. Epub 2005/04/09.
97. Carruba G, D'Agostino P, Miele M, Calabro M, Barbera C, Bella GD, et al. Estrogen regulates cytokine production and apoptosis in PMA-differentiated, macrophage-like U937 cells. J Cell Biochem. 2003; 90(1): 187-196. (Pubitemid 37052320)
98. Zhang X, Wang L, Zhang H, Guo D, Qiao Z, Qiao J. Estrogen inhibits lipopolysaccharide-induced tumor necrosis factor-alpha release from murine macrophages. Methods Find Exp Clin Pharmacol. 2001; 23(4): 169-173. (Pubitemid 32916732)
99. Chao TC, Van Alten PJ, Greager JA, Walter RJ. Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. Cell Immunol. 1995; 160(1): 43-49.
100. Zuckerman SH, Ahmari SE, Bryan-Poole N, Evans GF, Short L, Glasebrook AL. Estriol: a potent regulator of TNF and IL-6 expression in a murine model of endotoxemia. Inflammation. 1996; 20(6): 581-597. Epub 1996/12/01.
101. Ikejima K, Enomoto N, Iimuro Y, Ikejima A, Fang D, Xu J, et al. Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin. Am J Physiol. 1998; 274(4 Pt 1): G669-G676. Epub 1998/05/12.
102. Yang L, Hu Y, Hou Y. Effects of 17beta-estradiol on the maturation, nuclear factor kappa B p65 and functions of murine spleen CD11c-positive dendritic cells. Mol Immunol. 2006; 43(4): 357-366. (Pubitemid 41668845)
103. Hildebrand F, Hubbard WJ, Choudhry MA, Thobe BM, Pape HC, Chaudry IH. Are the protective effects of 17beta-estradiol on splenic macrophages and splenocytes after trauma-hemorrhage mediated via estrogen-receptor (ER)-alpha or ER-beta? Journal of Leukocyte Biology. 2006; 79(6): 1173-1180. Epub 2006/03/15.
104. Soucy G, Boivin G, Labrie F, Rivest S. Estradiol is required for a proper immune response to bacterial and viral pathogens in the female brain. Journal of Immunology. 2005; 174(10): 6391-6398. (Pubitemid 40663832)
105. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011; 117(14): 3720-3732. Epub 2011/02/10.
106. Ruh MF, Bi Y, D'Alonzo R, Bellone CJ. Effect of estrogens on IL-1beta promoter activity. J Steroid Biochem Mol Biol. 1998; 66(4): 203-210. Epub 1998/09/23.
107. Hu SK, Mitcho YL, Rath NC. Effect of estradiol on interleukin 1 synthesis by macrophages. Int J Immunopharmacol. 1988; 10(3): 247-52.
108. Mori H, Sawairi M, Itoh N, Hanabayashi T, Tamaya T. Effects of sex steroids on cell differentiation and interleukin-1 beta production in the human promyelocytic leukemia cell line HL-60. J Reprod Med. 1992; 37(10): 871-878.
109. Itoh Y, Hayashi H, Miyazawa K, Kojima S, Akahoshi T, Onozaki K. 17beta-estradiol induces IL-1alpha gene expression in rheumatoid fibroblast-like synovial cells through estrogen receptor alpha (ERalpha) and augmentation of transcriptional activity of Sp1 by dissociating histone deacetylase 2 from ERalpha. Journal of Immunology. 2007; 178(5): 3059-366. Epub 2007/02/22.
110. Miller AP, Feng W, Xing D, Weathington NM, Blalock JE, Chen YF, et al. Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries. Circulation. 2004; 110(12): 1664-1669. Epub 2004/ 09/09.
111. Ritz MF, Hausmann ON. Effect of 17beta-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats. Brain Res. 2008; 1203: 177-188. Epub 2008/03/05.
112. Calippe B, Douin-Echinard V, Laffargue M, Laurell H, Rana-Poussine V, Pipy B, et al. Chronic estradiol administration in vivo promotes the proinflammatory response of macrophages to TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway. Journal of Immunology. 2008; 180(12): 7980-7988.
113. Rogers A, Clowes JA, Pereda CA, Eastell R. Different effects of raloxifene and estrogen on interleukin-1beta and interleukin-1 receptor antagonist production using in vitro and ex vivo studies. Bone. 2007; 40(1): 105-110. Epub 2006/08/29.
114. Lewis DK, Johnson AB, Stohlgren S, Harms A, Sohrabji F. Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats. J Neuroimmunol. 2008; 195(1-2): 47-59. Epub 2008/03/11.
115. Rogers A, Eastell R. The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood. Bone. 2001; 29(1): 30-4. (Pubitemid 32707921)
116. Asai K, Hiki N, Mimura Y, Ogawa T, Unou K, Kaminishi M. Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model. Shock. 2001; 16(5): 340-343. Epub 2001/11/09.
117. Rachon D, Mysliwska J, Suchecka-Rachon K, Wieckiewicz J, Mysliwski A. Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausalwomen. The Journal of Endocrinology. 2002; 172(2): 387-395. Epub 2002/02/09.
118. Bengtsson AK, Ryan EJ, Giordano D, Magaletti DM, Clark EA. 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood. 2004; 104(5): 1404-1410. Epub 2004/05/15.
119. Huygen K, Palfliet K. Strain variation in interferon gamma production of BCG-sensitized mice challenged with PPD II. Importance of one major autosomal locus and additional sexual influences. Cell Immunol. 1984; 85(1): 75-81. (Pubitemid 14138980)
120. McMurray RW, Hoffman RW, Nelson W, Walker SE. Cytokine mRNA expression in the B/W mouse model of systemic lupus erythematosus-analyses of strain, gender, and age effects. Clin Immunol Immunopathol. 1997; 84(3): 260-268. (Pubitemid 27398025)
121. Satoskar A, Alexander J. Sex-determined susceptibility and differential IFN-gamma and TNF-alpha mRNA expression in DBA/2 mice infected with Leishmania mexicana. Immunology. 1995; 84(1): 1-4.
122. Karpuzoglu-Sahin E, Hissong BD, Ansar Ahmed S. Interferon-gamma levels are upregulated by 17-beta-estradiol and diethylstilbestrol. J Reprod Immunol. 2001; 52(1-2): 113-127. (Pubitemid 32923020)
123. Fox HS, Bond BL, Parslow TG. Estrogen regulates the IFN-gamma promoter. Journal of Immunology. 1991; 146(12): 4362-4367.
124. Karpuzoglu E, Phillips RA, Gogal RM Jr., Ansar Ahmed S. IFN-gamma-inducing transcription factor, T-bet is upregulated by estrogen in murine splenocytes: role of IL-27 but not IL-12. Mol Immunol. 2007; 44(7): 1808-1814. Epub 2006/10/19.
125. Gilmore W, Weiner LP, Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. Journal of Immunology. 1997; 158(1): 446-451. (Pubitemid 127483887)
126. Correale J, Arias M, Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. Journal of Immunology. 1998; 161(7): 3365-3374.
127. Gourdy P, Araujo LM, Zhu R, Garmy-Susini B, Diem S, Laurell H, et al. Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-gamma production by invariant natural killer T cells. Blood. 2005; 105(6): 2415-2420. (Pubitemid 40387040)
128. Liu Y, Guo YL, Zhou SJ, Liu F, Du FJ, Zheng XJ, et al. CREB is a positive transcriptional regulator of gamma interferon in latent but not active tuberculosis infections. Clin Vaccine Immunol. 2010; 17(9): 1377-1380. Epub 2010/ 08/06.
129. Pettersson A, Ciumas C, Chirsky V, Link H, Huang YM, Xiao BG. Dendritic cells exposed to estrogen in vitro exhibit therapeutic effects in ongoing experimental allergic encephalomyelitis. J Neuroimmunol. 2004; 156(1-2): 58-65. Epub 2004/10/07.
130. Matalka KZ. The effect of estradiol, but not progesterone, on the production of cytokines in stimulated whole blood, is concentration-dependent. Neuro Endocrinol Lett. 2003; 24(3-4): 185-191. Epub 2003/10/03.
131. de Oliveira AP, Domingos HV, Cavriani G, Damazo AS, Dos Santos Franco AL, Oliani SM, et al. Cellular recruitment and cytokine generation in a rat model of allergic lung inflammation are differentially modulated by progesterone and estradiol. Am J Physiol Cell Physiol. 2007; 293(3): C1120-C1128. Epub 2007/07/20.
132. Lambert KC, Curran EM, Judy BM, Milligan GN, Lubahn DB, Estes DM. Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+T cells independent of antigen presentation. Journal of Immunology. 2005; 175(9): 5716-5723. Epub 2005/10/21.
133. Hoch RV, Thompson DA, Baker RJ, Weigel RJ. GATA-3 is expressed in association with estrogen receptor in breast cancer. Int J Cancer. 1999; 84(2): 122-128. Epub 1999/03/30.
134. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol. 1996; 106(1): 127-133. Epub 1996/10/01.
135. Matthiesen L, Khademi M, Ekerfelt C, Berg G, Sharma S, Olsson T, et al. In-situ detection of both inflammatory and anti-inflammatory cytokines in resting peripheral blood mononuclear cells during pregnancy. J Reprod Immunol. 2003; 58(1): 49-59. Epub 2003/03/01.
136. Blaschitz C, Raffatellu M. Th17 cytokines and the gut mucosal barrier. J Clin Immunol. 2011; 30(2): 196-203. Epub 2010/02/04.
137. Kabir S. The role of interleukin-17 in the Helicobacter pylori induced infection and immunity. Helicobacter. 2011; 16(1): 1-8. Epub 2011/01/19.
138. DeLyria ES, Redline RW, Blanchard TG. Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology. 2009; 136(1): 247-256. Epub 2008/10/25.
139. McKinstry KK, Strutt TM, Buck A, Curtis JD, Dibble JP, Huston G, et al. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. Journal of immunology. 2009; 182(12): 7353-7363. Epub 2009/06/06.
140. Sieve AN, Meeks KD, Bodhankar S, Lee S, Kolls JK, Simecka JW, et al. A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection. European Journal of Immunology. 2009; 39(2): 426-438. Epub 2009/01/31.
141. Lin Y, Ritchea S, Logar A, Slight S, Messmer M, Rangel-Moreno J, et al. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity. 2009; 31(5): 799-810. Epub 2009/10/27.
142. Sellge G, Magalhaes JG, Konradt C, Fritz JH, Salgado-Pabon W, Eberl G, et al. Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity. Journal of Immunology. 2010; 184(4): 2076-2085. Epub 2010/01/22.
143. Lin JS, Kummer LW, Szaba FM, Smiley ST. IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection. Journal of Immunology. 2011; 186(3): 1675-1684. Epub 2010/12/22.
144. Khan D, Dai R, Karpuzoglu E, Ahmed SA. Estrogen increases, whereas IL-27 and IFN-gamma decrease, splenocyte IL-17 production in WT mice. European journal of Immunology. 2010; 40(9): 2549-2556. Epub 2010/07/14.
145. LeRoith T, Ansar Ahmed S. Regulatory T Cells and Viral Disease. In: Khatami M, editor. Inflammatory Diseases/ Book 1. ISBN 978-953-307-762-8. Chapter 2. Rijeka, Croatia: INTech-Open Access; 2011. pp. 121-144.
146. Bachy V, Williams DJ, Ibrahim MA. Altered dendritic cell function in normal pregnancy. J Reprod Immunol. 2008; 78(1): 11-21. Epub 2007/11/17.
147. Sysa P, Potter JJ, Liu X, Mezey E. Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by Sp1 and Smad2 transacting factors. DNA Cell Biol. 2009; 28(9): 425-434. Epub 2009/06/30.
148. Dhandapani KM, Wade FM, Mahesh VB, Brann DW. Astrocyte-derived transforming growth factor-{beta} mediates the neuroprotective effects of 17{beta}-estradiol: involvement of nonclassical genomic signaling pathways. Endocrinology. 2005; 146(6): 2749-2759. Epub 2005/ 03/05.
149. Mercier I, Colombo F, Mader S, Calderone A. Ovarian hormones induce TGF-beta(3) and fibronectin mRNAs but exhibit a disparate action on cardiac fibroblast proliferation. Cardiovasc Res. 2002; 53(3): 728-739. Epub 2002/02/28.
150. Alvarez Y, Municio C, Alonso S, Sanchez Crespo M, Fernandez N. The induction of IL-10 by zymosan in dendritic cells depends on CREB activation by the coactivators CREB-binding protein and TORC2 and autocrine PGE2. Journal of Immunology. 2009; 183(2): 1471-1479. Epub 2009/07/01.
151. Kube D, Platzer C, von Knethen A, Straub H, Bohlen H, Hafner M, et al. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine. 1995; 7(1): 1-7. Epub 1995/01/01.
152. Luo CY, Wang L, Sun C, Li DJ. Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro. Cellular & molecular immunology. 2011; 8(1): 50-58. Epub 2011/01/05.
153. Polanczyk MJ, Hopke C, Huan J, Vandenbark AA, Offner H. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol. 2005; 170(1-2): 85-92. Epub 2005/10/29.
154. Polanczyk MJ, Hopke C, Vandenbark AA, Offner H. Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). International Immunology. 2007; 19(3): 337-343. Epub 2007/02/03.
155. Offner H, Vandenbark AA. Congruent effects of estrogen and T-cell receptor peptide therapy on regulatory T cells in EAE and MS. International Reviews of Immunology. 2005; 24(5-6): 447-477. Epub 2005/12/02.
156. Tai P, Wang J, Jin H, Song X, Yan J, Kang Y, et al. Induction of regulatory T cells by physiological level estrogen. Journal of cellular physiology. 2008; 214(2): 456-464. Epub 2007/07/27.
157. Offner H, Polanczyk M. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Annals of the New York Academy of Sciences. 2006; 1089: 343-372. (Pubitemid 47092076)
158. Gold SM, Voskuhl RR. Estrogen and testosterone therapies in multiple sclerosis. Prog Brain Res. 2009; 175: 239-251. Epub 2009/08/08.
159. Polanczyk M, Zamora A, Subramanian S, Matejuk A, Hess DL, Blankenhorn EP, et al. The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha. Am J Pathol. 2003; 163(4): 1599-1605. (Pubitemid 37175106)
160. Morales LB, Loo KK, Liu HB, Peterson C, Tiwari-Woodruff S, Voskuhl RR. Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J Neurosci. 2006; 26(25): 6823-6833. (Pubitemid 44315243)
161. Xiao BG, Liu X, Link H. Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis. Steroids. 2004; 69(10): 653-659. Epub 2004/10/07.
162. Liu HY, Buenafe AC, Matejuk A, Ito A, Zamora A, Dwyer J, et al. Estrogen inhibition of EAE involves effects on dendritic cell function. J Neurosci Res. 2002; 70(2): 238-248.
163. Matejuk A, Dwyer J, Hopke C, Vandenbark AA, Offner H. 17Beta-estradiol treatment profoundly down-regulates gene expression in spinal cord tissue in mice protected from experimental autoimmune encephalomyelitis. Arch Immunol Ther Exp (Warsz). 2003; 51(3): 185-193. Epub 2003/08/05.
164. Gatson NN, Williams JL, Powell ND, McClain MA, Hennon TR, Robbins PD, et al. Induction of pregnancy during established EAE halts progression of CNS autoimmune injury via pregnancy-specific serum factors. J Neuroimmunol. 2011; 230(1-2): 105-113. Epub 2010/10/19.
165. Papenfuss TL, Powell ND, McClain MA, Bedarf A, Singh A, Gienapp IE, et al. Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity. J Immunol. 2011; 186(6): 3346-3355. Epub 2011/02/15.
166. Lelu K, Laffont S, Delpy L, Paulet PE, Perinat T, Tschanz SA, et al. Estrogen receptor alpha signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J Immunol. 2011; 187(5): 2386-2393. Epub 2011/08/04.
167. Lelu K, Delpy L, Robert V, Foulon E, Laffont S, Pelletier L, et al. Endogenous estrogens, through estrogen receptor alpha, constrain autoimmune inflammation in female mice by limiting CD4+ T-cell homing into the CNS. Eur J Immunol. 2010; 40(12): 3489-3498. Epub 2010/11/26.
168. Confavreux C, Hutchinson M, Hours MM, Cortinovis- Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. The New England Journal of Medicine. 1998; 339(5): 285-291. Epub 1998/07/31.
169. Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P, et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain. 2004; 127(Pt 6): 1353-1360. Epub 2004/05/08.
170. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol. 2002; 52(4): 421-428. Epub 2002/09/27.
171. Caulin-Glaser T, Watson CA, Pardi R, Bender JR. Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. The Journal of clinical investigation. 1996; 98(1): 36-42. Epub 1996/07/01.
172. Lockshin MD. Sex ratio and rheumatic disease: excerpts from an Institute of Medicine report. Lupus. 2002; 11(10): 662-666. Epub 2002/11/05.
173. Beeson PB. Age and sex associations of 40 autoimmune diseases. Am J Med. 1994; 96(5): 457-462. (Pubitemid 24156733)
174. Joseph FG, Scolding NJ. Neurolupus. Pract Neurol. 2010; 10(1): 4-15. Epub 2010/02/05.
175. Boumpas DT, Fessler BJ, Austin HA 3rd, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med. 1995; 123(1): 42-53. Epub 1995/ 07/01.
176. Lourenco EV, La Cava A. Cytokines in systemic lupus erythematosus. Curr Mol Med. 2009; 9(3): 242-254. Epub 2009/04/10.
177. Tenbrock K, Juang YT, Kyttaris VC, Tsokos GC. Altered signal transduction in SLE T cells. Rheumatology (Oxford). 2007; 46(10): 1525-1530. Epub 2007/06/26.
178. Zhang J, Jacobi AM, Wang T, Berlin R, Volpe BT, Diamond B. Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential. J Autoimmun. 2009; 33(3-4): 270-274. Epub 2009/04/29.
179. Yacoub Wasef SZ. Gender differences in systemic lupus erythematosus. Gend Med. 2004; 1(1): 12-17. Epub 2005/08/24.
180. Talal N. Natural history of murine lupus. Modulation by sex hormones. Arthritis Rheum. 1978; 21(5 Suppl): S58-S63. Epub 1978/06/01.
181. Sekigawa I, Fujishiro M, Yamaguchi A, Kawasaki M, Inui A, Nozawa K, et al. A new hypothesis of the possible mechanisms of gender differences in systemic lupus erythematosus. Clinical and experimental rheumatology. 2010; 28(3): 419-423. Epub 2010/05/13.
182. Walker SE. Estrogen and autoimmune disease. Clin Rev Allergy Immunol. 2011; 40(1): 60-65. Epub 2010/02/26.
183. Holroyd CR, Edwards CJ. The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus. Climacteric. 2009; 12(5): 378-386. Epub 2009/07/11.
184. Gompel A, Piette JC. Is there a place for postmenopausal hormone therapy use in women with lupus? Panminerva Med. 2008; 50(3): 247-254. Epub 2008/10/18.
185. Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol. 1999; 103(2 Pt 1): 282-288. (Pubitemid 29095834)
186. Kanda N, Tsuchida T, Tamaki K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 1999; 42(2): 328-337. (Pubitemid 29072851)
187. Cohen-Solal JF, Jeganathan V, Hill L, Kawabata D, Rodriguez-Pinto D, Grimaldi C, et al. Hormonal regulation of B-cell function and systemic lupus erythematosus. Lupus. 2008; 17(6): 528-532. Epub 2008/06/10.
188. Grimaldi CM, Jeganathan V, Diamond B. Hormonal regulation of B cell development: 17 beta-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint. Journal of Immunology. 2006; 176(5): 2703-2710. Epub 2006/02/24.
189. Ahmed SA, Aufdemorte TB, Chen JR, Montoya AI, Olive D, Talal N. Estrogen induces the development of autoantibodies and promotes salivary gland lymphoid infiltrates in normal mice. J Autoimmun. 1989; 2(4): 543-552. Epub 1989/08/01.
190. Franklin RD, Kutteh WH. Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones. Journal of Reproductive Immunology. 1999; 42(2): 93-106. Epub 1999/04/30.
191. Verthelyi D, Ahmed SA. 17 beta-estradiol, but not 5 alpha- dihydrotestosterone, augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL/6J mice. Endocrinology. 1994; 135(6): 2615-2622. Epub 1994/12/01.
192. Venkatesh J, Yoshifuji H, Kawabata D, Chinnasamy P, Stanevsky A, Grimaldi CM, et al. Antigen is required for maturation and activation of pathogenic anti-DNA antibodies and systemic inflammation. Journal of Immunology. 2011; 186(9): 5304-5312. Epub 2011/03/30.
193. Rider V, Abdou NI. Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol. 2001; 1(6): 1009-1024. (Pubitemid 32434421)
194. Durali D, de Goer de Herve MG, Giron-Michel J, Azzarone B, Delfraissy JF, Taoufik Y. In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment. Blood. 2003; 102(12): 4084-4089. (Pubitemid 37486992)
195. Sekigawa I, Naito T, Hira K, Mitsuishi K, Ogasawara H, Hashimoto H, et al. Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus. 2004; 13(4): 217-222. Epub 2004/06/05.
196. Perl A, Nagy G, Koncz A, Gergely P, Fernandez D, Doherty E, et al. Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE. Autoimmunity. 2008; 41(4): 287-297. Epub 2008/04/25.
197. Greenstein B, Roa R, Dhaher Y, Nunn E, Greenstein A, Khamashta M, et al. Estrogen and progesterone receptors in murine models of systemic lupus erythematosus. Int Immunopharmacol. 2001; 1(6): 1025-1035. (Pubitemid 32434422)
198. Inui A, Ogasawara H, Naito T, Sekigawa I, Takasaki Y, Hayashida Y, et al. Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Clin Rheumatol. 2007; 26(10): 1675-1678. Epub 2007/09/18.
199. Feng F, Nyland J, Banyai M, Tatum A, Silverstone AE, Gavalchin J. The induction of the lupus phenotype by estrogen is via an estrogen receptor-alpha-dependent pathway. Clin Immunol. 2010; 134(2): 226-236. Epub 2009/11/21.
200. Bynote KK, Hackenberg JM, Korach KS, Lubahn DB, Lane PH, Gould KA. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZBxNZW)F1 mice. Genes and Immunity. 2008; 9(2): 137-152. Epub 2008/01/18.
201. Li J, McMurray RW. Effects of estrogen receptor subtype-selective agonists on autoimmune disease in lupus-prone NZB/NZW F1 mouse model. Clin Immunol. 2007; 123(2): 219-226. Epub 2007/03/06.
202. Lee YJ, Shin KS, Kang SW, Lee CK, Yoo B, Cha HS, et al. Association of the oestrogen receptor alpha gene polymorphisms with disease onset in systemic lupus erythematosus. Ann Rheum Dis. 2004; 63(10): 1244-1249. Epub 2004/09/14.
203. Johansson M, Arlestig L, Moller B, Smedby T, Rantapaa-Dahlqvist S. Oestrogen receptor {alpha} gene polymorphisms in systemic lupus erythematosus. Ann Rheum Dis. 2005; 64(11): 1611-1617. Epub 2005/04/09.
204. Kawasaki M, Sekigawa I, Nozawa K, Kaneko H, Takasaki Y, Takamori K, et al. Changes in the gene expression of peripheral blood mononuclear cells during the menstrual cycle of females is associated with a gender bias in the incidence of systemic lupus erythematosus. Clinical and Experimental Rheumatology. 2009; 27(2): 260-266. Epub 2009/05/29.
205. Sedy JR, Gavrieli M, Potter KG, Hurchla MA, Lindsley RC, Hildner K, et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol. 2005; 6(1): 90-98. Epub 2004/11/30.
206. Cai G, Freeman GJ. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol Rev. 2009; 229(1): 244-258. Epub 2009/05/12.
207. Koga M, Kawasaki A, Ito I, Furuya T, Ohashi J, Kyogoku C, et al. Cumulative association of eight susceptibility genes with systemic lupus erythematosus in a Japanese female population. J Hum Genet. 2011; 56(7): 503-507. Epub 2011/05/13.
208. Salloum R, Niewold TB. Interferon regulatory factors in human lupus pathogenesis. Translational Research: The Journal of Laboratory and Clinical Medicine. 2011; 157(6): 326-331. Epub 2011/05/18.
209. Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, Suematsu R, et al. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Arthritis Rheum. 2011; 63(3): 738-748. Epub 2011/02/10.
210. Shen H, Panchanathan R, Rajavelu P, Duan X, Gould KA, Choubey D. Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity. Journal of Molecular Cell Biology. 2010; 2(5): 284-290. Epub 2010/08/31.
211. Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Translational Research: The Journal of Laboratory and Clinical Medicine. 2011; 157(4): 163-179. Epub 2011/03/23.
212. Dai R, Phillips RA, Zhang Y, Khan D, Crasta O, Ahmed SA. Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood. 2008; 112(12): 4591-4597. Epub 2008/09/16.
213. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2): 215-233. Epub 2009/01/27.
214. Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, McManus MT, et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med. 2008; 205(9): 1983-1991. Epub 2008/08/30.
215. Pauley KM, Cha S, Chan EK. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun. 2009; 32(3-4): 189-194. Epub 2009/03/24.
216. Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S, Stewart GJ, et al. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PloS One. 2010; 5(8): e12132. Epub 2010/08/17.
217. Lindberg RL, Hoffmann F, Mehling M, Kuhle J, Kappos L. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. European Journal of Immunology. 2010; 40(3): 888-898. Epub 2010/02/12.
218. Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S, et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nature Immunology. 2009; 10(12): 1252-1259. Epub 2009/10/20.
219. Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PloS One. 2009; 4(10): e7440. Epub 2009/10/14.
220. Otaegui D, Baranzini SE, Armananzas R, Calvo B, Munoz-Culla M, Khankhanian P, et al. Differential micro RNA expression in PBMC from multiple sclerosis patients. PloS One. 2009; 4(7): e6309. Epub 2009/07/21.
221. Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain. 2009; 132(Pt 12): 3342-3352. Epub 2009/12/03.
222. Yang B, Guo H, Zhang Y, Chen L, Ying D, Dong S. MicroRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9. PloS One. 2011; 6(7): e21679. Epub 2011/07/30.
223. Bussolati B, Moggio A, Collino F, Aghemo G, D'Armento G, Grange C, et al. Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance. Am J Physiol Renal Physiol. 2011. Epub 2011/09/09.
224. Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J, Mendelson CR. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107(48): 20828-20833. Epub 2010/11/17.
225. Xia H, Ng SS, Jiang S, Cheung WK, Sze J, Bian XW, et al. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun. 2010; 391(1): 535-541. Epub 2009/11/26.
226. Chan YC, Khanna S, Roy S, Sen CK. miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J Biol Chem. 2010; 286(3): 2047-2056. Epub 2010/11/18.
227. Oh HK, Tan AL, Das K, Ooi CH, Deng NT, Tan IB, et al. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res. 2011; 17(9): 2657-2667. Epub 2011/03/19.
228. Lashine YA, Seoudi AM, Salah S, Abdelaziz AI. Expression signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus. Clinical and experimental rheumatology. 2011; 29(2): 351-357. Epub 2011/03/10.
229. Zhao S, Wang Y, Liang Y, Zhao M, Long H, Ding S, et al. MicroRNA-126 regulates DNA methylation in CD4+Tcells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum. 2011; 63(5): 1376-1386. Epub 2011/05/04.
230. Hai-yan W, Yang L, Mei-hong C, Hui Z. Expression of MicroRNA-146a in peripheral blood mononuclear cells in patients with systemic lupus Erythematosus. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011; 33(2): 185-188. Epub 2011/05/03.
231. Zhao X, Tang Y, Qu B, Cui H, Wang S, Wang L, et al. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum. 2010; 62(11): 3425-3435. Epub 2010/07/01.
232. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009; 60(4): 1065-1075. Epub 2009/04/01.
233. Stagakis E, Bertsias G, Verginis P, Nakou M, Hatziapostolou M, Kritikos H, et al. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis. 2011; 70(8): 1496-506. Epub 2011/05/24.
234. Dai R, Zhang Y, Khan D, Heid B, Caudell D, Crasta O, et al. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PloS One. 2010; 5(12): e14302. Epub 2010/12/21.
235. Ansar Ahmed S, Penhale WJ, Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol. 1985; 121(3): 531-551. (Pubitemid 16183373)